Tom Cooper, lead cardiology pharmacist at Imperial College Healthcare NHS Trust in London, speaks to C+D clinical editor Naimah Callachand in the latest C+D podcast.
When asked about handling patients with COVID-19 who had been taking angiotensin-converting enzyme inhibitors, a question from a listener, he says: “Patients on those medications should be continuing those drugs unless specifically advised to stop.”
COVID-19 is “not a reason to stop” taking cardiac medicines, he says. There is “no clear evidence” that taking the drugs worsen outcomes for these patients, despite discussions about this being a possibility in spring.
The podcast offers a new follow-up interview with Mr Cooper after his appearance on C+D’s webinar at the Clinical Pharmacy Congress on September 24, which explored the range of effects of ‘long COVID’ on patients.
You can listen to the podcast below. Alternatively, subscribe to C+D's podcast on your preferred podcast app by searching “Chemist+Druggist” or on Soundcloud.
Please note, the sound quality of this podcast may be affected as it has been recorded remotely during the COVID-19 outbreak.
Listen to follow-up interviews with two other panellists from the webinar: Oksana Pzyik and Harpreet Chana.
